JP Morgan Chase’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-45,700
Closed -$514K 7298
2024
Q4
$514K Buy
+45,700
New +$534K ﹤0.01% 5024

Other funds holding ALHC

JP Morgan Chase's ALHC Position: Q2 2026 in Review

JP Morgan Chase increased its Alignment Healthcare (ALHC) stake by 165% in Q2 2026, buying an estimated $5.96M and bringing the position to 499,144 shares worth $11.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2665.

JP Morgan Chase first reported a position in ALHC in Q1 2021 and has held it in 22 quarters since. The position peaked at $13.9M in Q1 2025. 186 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

  • JP Morgan Chase held 499,144 shares of Alignment Healthcare worth $11.8M as of Q2 2026.
  • JP Morgan Chase bought 310,610 Alignment Healthcare shares in Q2 2026, an estimated $5.96M.
  • Alignment Healthcare made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #2665 holding.
  • JP Morgan Chase first reported a position in Alignment Healthcare in Q1 2021 and has held it in 22 quarters since.
  • JP Morgan Chase's Alignment Healthcare position peaked at $13.9M in Q1 2025.
  • 186 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.